ASTRAZENECA PLC

ASTRAZENECA PLC

• AstraZeneca in $560 m deal for respiratory firm

  British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for ... 

• AstraZeneca to pay about $260M for Omthera Pharma

  British drugmaker AstraZeneca PLC plans to spend about $260 million on Omthera Pharmaceuticals Inc., a specialty drug developer with only 14 employees ... 

• AstraZeneca Q1 net profit plunges 31 percent

  British drug maker AstraZeneca PLC, facing generic competition for some of its biggest products, says first-quarter profits fell 31 percent. 

• 

  India's rejection of drug patent could reverberate

  The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the ... 

• FDA OKs first-of-its-kind diabetes drug from J&J

  The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood ... 

• AstraZeneca to cut 2,300 jobs in business overhaul

  Struggling drug company AstraZeneca outlined a major restructuring of its business on Thursday, including some 2,300 job cuts worldwide as it ... 

• 

  AstraZeneca reorg to cut 1,600 jobs in US, UK

  Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new ... 

• Drugmakers, Interpol ramp up fight against fakes

  More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against ... 

• AstaZeneca in patent warning as net profit falls

  Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in ...